Report out today?

The next few months of the Covid-19 pandemic will be among “the most difficult in the public health history of this nation,” Dr. Robert Redfield, the director of the Centers for Disease Control and Prevention, said Wednesday.

Redfield, speaking at an event hosted by the U.S. Chamber of Commerce, said that about 90% of hospitals in the country are in “hot zones and the red zones.” He added that 90% of long-term care facilities are in areas with high level of spread.

“So we are at a very critical time right now about being able to maintain the resilience of our health-care system,” Redfield said. “The reality is December and January and February are going to be rough times. I actually believe they’re going to be the most difficult in the public health history of this nation, largely because of the stress that’s going to be put on our health-care system.”

The next few months of the Covid-19 pandemic will be among “the most difficult in the public health history of this nation,” Dr. Robert Redfield, the director of the Centers for Disease Control and Prevention, said Wednesday.

Redfield, speaking at an event hosted by the U.S. Chamber of Commerce, said that about 90% of hospitals in the country are in “hot zones and the red zones.” He added that 90% of long-term care facilities are in areas with high level of spread.

“So we are at a very critical time right now about being able to maintain the resilience of our health-care system,” Redfield said. “The reality is December and January and February are going to be rough times. I actually believe they’re going to be the most difficult in the public health history of this nation, largely because of the stress that’s going to be put on our health-care system.”

The next few months of the Covid-19 pandemic will be among “the most difficult in the public health history of this nation,” Dr. Robert Redfield, the director of the Centers for Disease Control and Prevention, said Wednesday.

Redfield, speaking at an event hosted by the U.S. Chamber of Commerce, said that about 90% of hospitals in the country are in “hot zones and the red zones.” He added that 90% of long-term care facilities are in areas with high level of spread.

“So we are at a very critical time right now about being able to maintain the resilience of our health-care system,” Redfield said. “The reality is December and January and February are going to be rough times. I actually believe they’re going to be the most difficult in the public health history of this nation, largely because of the stress that’s going to be put on our health-care system.”

The next few months of the Covid-19 pandemic will be among “the most difficult in the public health history of this nation,” Dr. Robert Redfield, the director of the Centers for Disease Control and Prevention, said Wednesday.

Redfield, speaking at an event hosted by the U.S. Chamber of Commerce, said that about 90% of hospitals in the country are in “hot zones and the red zones.” He added that 90% of long-term care facilities are in areas with high level of spread.

“So we are at a very critical time right now about being able to maintain the resilience of our health-care system,” Redfield said. “The reality is December and January and February are going to be rough times. I actually believe they’re going to be the most difficult in the public health history of this nation, largely because of the stress that’s going to be put on our health-care system.”

Will up very soon. Report very near already. Still 2 weeks to go.

The report show a lot of improvement in revenue, I think this Monday still can up.

Report out. Good profit

Result out. Good profit

Covid testing faces delays — again — as demand spikes ahead of the holidays

PUBLISHED THU, NOV 19 202010:29 AM ESTUPDATED 6 MIN AGO
Will Feuer
@WILLFOIA
With the holidays approaching, some companies calling workers back to the office and anxiety over the virus rising with the daily case count, demand for accurate Covid-19 testing is spiking.
An average of 1.6 million Covid-19 tests were run every day over the last week, compared with a seven-day average of less than 900,000 in July.
The surge in demand is leading to long lines for testing, shortages in testing kits and other supplies and processing delays across the country.

Stocks fall as coronavirus cases rise, jobless claims data disappoint

Good time to collect now

Sure can. Malaysia boleh

Vaccines news no special already

Vaccines news is not new for glove counter. Last week already knew

Vaccine news nothing special to glove counter. Last week already knew this news.

Nothing special news, already knew having vaccine since last week

Good

Report out

https://www.cnbc.com/2020/11/18/what-are-the-big-challenges-to-mass-producing-a-coronavirus-vaccine.html?__source=iosappshare%7Cnet.whatsapp.WhatsApp.ShareExtension

Good sign to rebound

Any news why today up a lot?

Nothing special news

The price already factor in last week during first vaccine announced. I believe it won’t panic selling happen tomorrow

I agree with you

Not a surprise for second news and already kena teruk last week.

No surprise of vaccine news because last week already kena teruk

No surprise on vaccine news anymore. Last week already kena teruk

Time to buy

https://edition.cnn.com/2020/11/09/us/biden-mask-mandate-nationwide-trnd/index.html

https://www.businessinsider.com/new-pfizer-vaccine-will-not-save-the-holidays-experts-2020-11?utm_campaign=sf-bi-ti&utm_source=facebook.com&utm_medium=social

No good for glove counter

No good for glove

https://malaysiastock.biz/Company-Announcement.aspx?id=1271036

Register under fda

Dividend 1 cent

Consider good news?

Good

So good luck for thong guan today

Tomorrow will fly again

This Kyy cannot believe. You sell and he will collect more

I think he got reason to sell his share

Yes, I believe someone is buying to increase his share percentage

After today, his share become 1-2% only.

I don’t think bad news

This Monday will up

Good counter

Another good counter on face mask, Prolexus, still very undervalue

Tomorrow will fly again

Try to see this counter, Prolexus. Worth to buy